The Chronic Disease Pledge is a 10-year commitment by ACHP’s Board of Directors to make progress toward reducing the incidence of chronic disease.

ACHP members signed the Chronic Disease Pledge, committing to address and reduce the incidence of diabetes and hypertension across the country. Our member plans have outlined specific and tailored goals for their communities to address chronic disease through a social determinants of health lens, implementing programs and expanding educational initiatives.

The origins of this pledge are in Health Care 2030: ACHP’s Roadmap to Reform, a forward-looking report outlining practical changes for immediate and long-term improvement in the U.S. health care system.  

Since the Chronic Disease Pledge was signed in 2023, ACHP members have already witnessed significant improvements in the well-being of their populations. 

“Each of us likely knows someone living with at least one chronic disease, and we have all witnessed the toll these conditions take on individuals and families. I’m so proud to see our members stepping forward and holding themselves accountable for improving the health of their communities in these critical areas.”

–Ceci Connolly, ACHP President & CEO, in announcing the Chronic Disease Pledge

Most recently, ACHP received a $1.54 million grant from The Leona M. and Harry B. Helmsley Charitable Trust supporting the pledge to improve diabetes outcomes. The research will focus on the utilization and adoption of continuous glucose monitoring (CGM) to help improve outcomes and enhance quality of life. ACHP will partner with HealthPartners Institute International Diabetes Center (IDC) on this 18-month project to advocate for increasing appropriate CGM use, support evidence of its positive impacts and develop potential pilot interventions.